C
Commodore Capital LP
+ Con en carteraJATT
+40.77%
Rentabilidad a 3 meses
$10.340
+0.091 (+0.88%)Al cierre
Loading chart…
- Máximo
- 10.340
- Apertura
- 10.275
- Precio medio ponderado por volumen
- 10.32
- Volumen
- 658.00
- Capitalización
- —
- Mínimo
- 10.275
- Importe
- 6.79K
- EV/EBITDA, TTM
- 0.00
JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue.
Análisis de IA of JATT II Acquisition Corp (JATT)
MantenerCurrently, Zura Bio Ltd (JATT) is not a strong buy due to its low price performance and negative earnings. The stock is trading at $10.25, which is only 1.9% above its 52-week low of $9.99. Additionally, the RSI is at 35.681, indicating that the stock is approaching oversold territory but is not yet a clear buy signal. The forward P/E ratio is 0, showing no expected earnings growth, which raises concerns about its profitability.
Métricas de valoración
El PER previsto actual de JATT II Acquisition Corp (JATT) es 0.00, frente a su media de 5 años de .
Ballenas con JATT en cartera
Cronología de eventos
Noticias
8.508-27NewsfilterJATT III Acquisition Corp Successfully Completes IPO
- 8.508-25Newsfilter
JATT III Acquisition Corp Prices Initial Public Offering
8.506-29PRnewswireTalawar and JATT II Announce Business Combination Agreement
- 8.506-29Newsfilter
Talawar and JATT II Announce Business Combination Agreement
- 8.504-20Newsfilter
JATT II Acquisition Corp Successfully Completes IPO
Preguntas frecuentes sobre JATT, respondidas por Alphio AI
JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue. It operates in the Financials sector.
Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low price performance and negative earnings. The stock is trading at $10.25, which is only 1.9% above its 52-week low of $9.99. Additionally, the RSI is at 35.681, indicating that the stock is approaching oversold territory but is not yet a clear buy signal. The forward P/E ratio is 0, showing no expected earnings growth, which raises concerns about its profitability.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarArtículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.